Guardant Well being and James Van Der Beek Group As much as Elevate Consciousness About New Advances in Colorectal Most cancers Screening for Adults 45+

Guardant Well being and James Van Der Beek Group As much as Elevate Consciousness About New Advances in Colorectal Most cancers Screening for Adults 45+

• 75% of sufferers who die from colorectal most cancers (CRC) usually are not screened, actually because conventional choices are seen as disagreeable or inconvenient

• Guardant’s FDA-approved Protect provides screening with a easy blood draw from any prescribing healthcare supplier for adults 45+ at common danger for CRC

• After a CRC prognosis, Van Der Beek is talking up for the primary time to advocate to get extra individuals screened

Guardant Well being, Inc. (Nasdaq: GH), a number one precision oncology firm, at the moment introduced its partnership with actor and well being advocate James Van Der Beek to extend consciousness about colorectal most cancers (CRC) screening and the Protect™ blood check. Authorised by the U.S. Meals and Drug Administration (FDA) final 12 months, Protect provides a handy and extra nice new choice for CRC screening for eligible people 45+.

This press launch options multimedia. View the total launch right here: https://www.businesswire.com/information/house/20250728751799/en/

Identified for iconic roles in Varsity Blues, Guidelines of Attraction and Don’t Belief the B in Condo 23, Van Der Beek has created many memorable characters in his 20+-year TV and movie profession, each on display and as a producer, director and author. Van Der Beek went public together with his CRC prognosis in November 2024 to encourage others to take management of their well being. At the moment marks the primary time he’s talking out concerning the essential significance of staying updated with CRC screening pointers.

“I used to be 46 years previous, in nice bodily form, and had no concept I used to be dwelling with stage 3 colorectal most cancers. It’s the second most dangerous most cancers, however essentially the most curable when caught in its early levels, making screening essential,” stated Van Der Beek. “I used to be relieved to find out about Guardant’s Protect blood check as a result of it’s a extra nice and handy strategy to get screened, particularly for individuals who’ve been hesitating. I’ve discovered loads on my most cancers journey, however I wouldn’t want this on anybody. Merely put, getting screened can save your life. In case you’re 45 or older, be sure you discuss to your physician about screening pointers and your choices.”

CRC is a big well being concern with over 50,000 People dying from the illness every year, making it the second most dangerous most cancers within the U.S. Early detection is essential, because the five-year survival fee is over 90% when CRC is caught in its early levels, however plummets to 13% in late levels when signs normally seem. Regardless of these odds, greater than 50 million individuals – one in three American adults age 45 and over – keep away from screening partly as a result of conventional strategies are seen as disagreeable or inconvenient.

“We’re grateful to James for the work he has completed to lift consciousness together with his private story that exhibits the significance of screening and early detection,” stated AmirAli Talasaz, Guardant Well being co-CEO. “Our purpose is to make sure that everybody who must be screened for colorectal most cancers will get screened – and the Protect blood check is a significant step ahead in making screening extra handy and accessible throughout the nation. We’re dedicated to saving lives by means of early detection and – with James’ assist – we hope extra People are inspired to take this essential step.”

“In my major care apply, I’m on the frontlines of colorectal most cancers and screenings are among the best instruments we now have, serving to us to catch and deal with colorectal most cancers at early levels,” stated Dr. Angel Lazo, an inside medication doctor in New Jersey. “In my apply, it may be troublesome for sufferers to display with conventional strategies. Including the choice of Protect has made it rather more handy and expanded screening to extra individuals, giving peace of thoughts to them – and to me as their physician.”

Protect is the primary blood check accredited by the U.S. Meals and Drug Administration as a major screening choice for CRC. It’s meant for adults age 45 and older at common danger for the illness and may be ordered by any prescribing healthcare supplier. With Protect, people can endure screening with a easy blood draw and outcomes are usually obtainable inside two weeks. Not too long ago, the Nationwide Complete Most cancers Community included the Protect blood check in its up to date CRC screening pointers, paving the way in which for improved affected person entry and extra main scientific guideline inclusions.

For extra details about the Protect blood check, go to www.ShieldCancerScreen.com.

About Guardant Well being

Guardant Well being is a number one precision oncology firm targeted on guarding wellness and giving each individual extra time free from most cancers. Based in 2012, Guardant is reworking affected person care and accelerating new most cancers therapies by offering essential insights into what drives illness by means of its superior blood and tissue assessments, real-world knowledge and AI analytics. Guardant assessments assist enhance outcomes throughout all levels of care, together with screening to search out most cancers early, monitoring for recurrence in early-stage most cancers, and remedy choice for sufferers with superior most cancers. For extra info, go to guardanthealth.com and comply with the corporate on LinkedIn, X (Twitter) and Fb.

Ahead-Wanting Statements

This press launch accommodates forward-looking statements throughout the that means of federal securities legal guidelines, together with statements relating to the potential utilities, values, advantages and benefits of Guardant Well being’s liquid biopsy assessments or assays, which contain dangers and uncertainties that might trigger the precise outcomes to vary materially from the anticipated outcomes and expectations expressed in these forward-looking statements. These statements are based mostly on present expectations, forecasts and assumptions, and precise outcomes and outcomes may differ materially from these statements because of plenty of elements. These and extra dangers and uncertainties that might have an effect on Guardant Well being’s monetary and working outcomes and trigger precise outcomes to vary materially from these indicated by the forward-looking statements made on this press launch embody these mentioned beneath the captions “Danger Components” and “Administration’s Dialogue and Evaluation of Monetary Situation and Outcomes of Operation” and elsewhere in its Annual Report on Kind 10-Ok for the 12 months ended December 31, 2024, and in its different reviews filed with or furnished to the Securities and Trade Fee thereafter. The forward-looking statements on this press launch are based mostly on info obtainable to Guardant Well being as of the date hereof, and Guardant Well being disclaims any obligation to replace any forward-looking statements offered to mirror any change in its expectations or any change in occasions, circumstances, or circumstances on which any such assertion is predicated, besides as required by regulation. These forward-looking statements shouldn’t be relied upon as representing Guardant Well being’s views as of any date subsequent to the date of this press launch.

Investor Contact:

Zarak Khurshid

buyers@guardanthealth.com

Media Contact:

Meaghan Smith

press@guardanthealth.com

View supply model on businesswire.com: https://www.businesswire.com/information/house/20250728751799/en/